India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

 

Issue dated - 10th February 2005

Home > Edit

Withdrawal syndrome
The drug trade in India for the past few months has been receiving special attention from the regulators and the concerned ministries. Even as the issue of huge trade margins and ‘MRP inclusive of excise’ continue to elude proper resolution, the trade is now caught up in a ‘psychotropic’ seizure of sorts, first giving Mumbai blues and then an all-India depression subsequently.

Anxiety over psychotropic drugs ban
A possible solution to this problem would be a carefully planned, stepped-up approach in implementation, phasewise, covering one category of a drugs at a time, says Raj Vaidya.

  
INSIDE PHARMA
IN THE NEWS
EDIT
OPED
HAPPENINGS
CORPORATE
TECHNOLOGY
RESEARCH
MARKETPLACE
CONVERSATION
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 

© Copyright 2001: Indian Express Newspapers (Bombay) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Bombay) Limited. Site managed by BPD.